K191581 is an FDA 510(k) clearance for the Endoskeleton TL Interbody Fusion Device, Endoskeleton TL Hyperlordotic Interb.... Classified as Intervertebral Fusion Device With Integrated Fixation, Lumbar (product code OVD), Class II - Special Controls.
Submitted by Titan Spine, Inc. (Mequon, US). The FDA issued a Cleared decision on January 8, 2020 after a review of 208 days - an extended review cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Titan Spine, Inc. devices